ETTAL MICROCONSULT AS

Closed at September 6th, 2024

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: EL
Egil Lingaas1950
Operation time: 18 years; - Mar 30, 2006 to Sep 6, 2024
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 100; 1 share class
Total number of shareholders: 4; persons

Financials

Annual total result 2023: 2,742; NOK
Total equity 2023: 553,517; NOK

Last update: Aug 29, 2024

Management

Board

Name	Role	Shares
EL Egil Lingaas 1950	Chairman	70 % directly
TL Terje Lingaas 1981	Board Member	10 % directly
TL Trond Lingaas 1983	Board Member	10 % directly

Others

Name	Role	Shares
B BDO AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
EL Egil Lingaas 1950	Chairman	70 % directly
TL Terje Lingaas 1981	Board Member	10 % directly
TL Trond Lingaas 1983	Board Member	10 % directly
AL Arve Lingaas 1988	-	10 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
EL Egil Lingaas 1950	Ordinary shares	70	70 %
AL Arve Lingaas 1988	Ordinary shares	10	10 %
TL Terje Lingaas 1981	Ordinary shares	10	10 %
TL Trond Lingaas 1983	Ordinary shares	10	10 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	0	0	0
Annual Total Result	2,742	-6,246	-9,704
Total assets	555,987	553,245	559,491
Total liabilities	2,470	2,470	2,470
Total equity	553,517	550,775	557,021

P&L

Year	2023	2022	2021
Total operating income	0	0	0
Total operating costs	10,175	9,846	10,574
Operating result	-10,175	-9,846	-10,574
Financial income/costs	12,917	3,601	870
Profit before tax	2,742	-6,246	-9,704
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	2,742	-6,246	-9,704

Balance overview

Year	2023	2022	2021
Total fixed assets	0	0	0
Total current assets	555,987	553,245	559,491
Total assets	555,987	553,245	559,491
Short term debt	2,470	2,470	2,470
Long term debt	0	0	0
Total liabilities	2,470	2,470	2,470
Contributed capital	100,000	100,000	100,000
Retained earnings	453,517	450,775	457,021
Total equity	553,517	550,775	557,021
Total equity and liabilities	555,987	553,245	559,491

ETTAL MICROCONSULT AS989 411 144